In zebrafish, ketamine causes changes a brain circuit involved in "giving up." That may help explain how the drug helps ...

The well-funded biotech lost most of its value after its drug flunked a late-stage trial. One analyst described the results ...

Neuroscience company Neumora Therapeutics (NMRA) announced today that its experimental treatment for depression, Navacaprant, ...

Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...

Patients who received the drug, called navacaprant, showed no more improvement in depressive symptoms than people who ...

Purpose: The association of antipsychotic and antidepressant drugs with Q-T interval prolongation is reviewed. Summary: Prolongation of the Q-T interval can be of particular concern to ...

The study, first of the three late-stage trials, was testing the drug, navacaprant, in patients with major depressive ...

Studies show that antidepressants don’t always work. One psychologist explains how to take control of negative thoughts ...

Neumora Therapeutics, Inc. (NASDAQ:NMRA) stock traded lower after the company released data from the Phase 3 KOASTAL-1 Study ...

Despite being a first-line treatment for adolescent depression and anxiety, antidepressant drugs appear to have questionable efficacy and carry an increased risk of adverse effects in this population.

Studies show psilocybin from mushrooms could revolutionize depression treatment offering hope to millions who don't respond ...

Kingston: One of the most popular new year's resolutions is making a commitment to healthier eating. Whether that's eating ...